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Abstract
Background: The Health and Social Care Act mandated research use as a core consideration of health service
commissioning arrangements in England. We undertook a controlled before and after study to evaluate whether
access to a demand-led evidence briefing service improved the use of research evidence by commissioners
compared with less intensive and less targeted alternatives.
Methods: Nine Clinical Commissioning Groups (CCGs) in the North of England received one of three interventions:
(A) access to an evidence briefing service; (B) contact plus an unsolicited push of non-tailored evidence; or (C)
unsolicited push of non-tailored evidence. Data for the primary outcome measure were collected at baseline and
12 months using a survey instrument devised to assess an organisations’ ability to acquire, assess, adapt and apply
research evidence to support decision-making. Documentary and observational evidence of the use of the outputs
of the service were sought.
Results: Over the course of the study, the service addressed 24 topics raised by participating CCGs. At 12 months,
the evidence briefing service was not associated with increases in CCG capacity to acquire, assess, adapt and apply
research evidence to support decision-making, individual intentions to use research findings or perceptions of CCG
relationships with researchers. Regardless of intervention received, participating CCGs indicated that they remained
inconsistent in their research-seeking behaviours and in their capacity to acquire research. The informal nature of
decision-making processes meant that there was little traceability of the use of evidence. Low baseline and follow-
up response rates and missing data limit the reliability of the findings.
Conclusions: Access to a demand-led evidence briefing service did not improve the uptake and use of research
evidence by NHS commissioners compared with less intensive and less targeted alternatives. Commissioners appear
well intentioned but ad hoc users of research. Further research is required on the effects of interventions and
strategies to build individual and organisational capacity to use research.
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Background
In the National Health Service (NHS) in England, Clin-
ical Commissioning Groups (CCGs) are responsible for
the planning and commissioning of health care services
in a defined geographical area. In 2012, the Health and
Social Care Act mandated research use as a core consid-
eration in health service commissioning arrangements
[1]. Each CCG now must, in the exercise of their func-
tions, promote the use in the health service evidence ob-
tained from research [1].
NHS commissioners now have a key role in improving
the uptake and use of knowledge to inform commission-
ing and decommissioning of services, and there is a sub-
stantive evidence base upon which they can draw.
However, uptake of this knowledge to increase efficiency,
reduce practice variations and ensure best use of finite
resources within the NHS is not always realised. This is
in part through system failings to fully implement inter-
ventions and procedures of known effectiveness [2, 3].
There has also been rapid, sometimes policy-driven
deployment of unproven interventions despite known
uncertainties relating to costs, impacts on service utilisa-
tion and clinical outcomes, patient experience and sus-
tainability [4]. And the NHS has been slow to identify
and disinvest in those interventions known to be of low
or no clinical value [5].
Whilst it is widely acknowledged that different sources
of knowledge combine in evidence-informed decision-
making [6] and that the process itself is highly contin-
gent and context dependent [7], the value of systematic
reviews to health care decision-making is well recog-
nised [8, 9]. However, a number of challenges have
undermined the usefulness of systematic reviews in
decision-making contexts [8, 10–15]. These include diffi-
culties in locating and appraising relevant reviews, a lack
of timeliness or user friendliness and a perceived failure
of reviews to address relevant questions, contextualize
the findings or make actionable policy recommenda-
tions. An initiative aiming to enhance uptake of system-
atic review evidence by NHS commissioners and senior
managers was developed as an adjunct to the implemen-
tation theme of the NIHR CLAHRC for Leeds, York and
Bradford [16]. Development of the service was informed
by a scoping review of existing resources [17] and previ-
ous experience in producing and disseminating the re-
nowned Effective Health Care and Effectiveness Matters
series of bulletins. The service attempted to inform real
decisions by making use of existing sources of synthe-
sised research evidence. The service approach was both
consultative and responsive and involved building rela-
tions and having regular contact (face to face and email)
with a range of NHS commissioners and managers. This
enabled the team to discuss issues and for those that re-
quired a more considered response, formulate questions
from which contextualised briefings could be produced
and their implications discussed. In doing so, we utilised
a framework designed to clarify the problem and frame
the question to be addressed [18]. The service had some
early impacts notably including work to inform service
reconfiguration for adolescent eating disorders; enabling
commissioners to invest in more services on a more
cost-effective outpatient basis [19].
Although feedback from users was consistently posi-
tive, the evidence briefing service had been developmen-
tal and no formal evaluation had been conducted. The
service as constituted was a resource-intensive endeav-
our and made use of the considerable review capacity
and infrastructure available at the Centre for Reviews
and Dissemination (CRD). As such, this study aimed to
assess whether access to a demand-led evidence briefing
service would improve the uptake and use of research
evidence by NHS commissioners compared with less
intensive and less targeted alternatives.
Methods
This was a controlled before and after study involving
CCGs in the North of England [20]. The study protocol
has been published previously [21].
Setting, participants and recruitment
Nine CCGs from one geographical area in England
agreed to participate, and the recruitment process is
presented in Fig. 1. We had originally anticipated that
we would invite 9–10 CCGs from one geographical area
based on the 2012/13 Primary Care Trust (PCT) cluster
arrangements. By the start of the study, some consolida-
tion in the proposed commissioning arrangements had
occurred in the transition from PCTs to CCGs and so
seven CCGs were invited to participate. Of these, six
agreed to participate. One CCG declined, intimating that
they could not participate in any intervention. No CCG
asked for financial reimbursement for taking part in the
study.
We had originally intended to randomly allocate CCGs
to interventions. However, a combination of expressed
preferences (one CCG indicated that they would like to be
a ‘control’) and the prospect of further consolidation in
commissioning arrangements meant that this was not
feasible. Taking these factors into account, two CCGs were
allocated to receive on-demand access to the evidence
briefing service, three coterminous CCGs (who were likely
to merge) received on-demand access to advice and sup-
port from the CRD team and one to a ‘standard service’
control arm. After this initial allocation, research leads
from CCGs in a neighbouring geographical area
approached the team and asked to participate. After dis-
cussions with representatives of the five CCGs, a further
three CCGs were recruited as ‘standard service’ controls.
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Interventions
Participating CCGs received one of three interventions
aimed at supporting the use of research evidence in their
decision-making:
A. Contact plus responsive push of tailored evidence
CCGs in this arm received on-demand access to an
evidence briefing service provided by research team
members at CRD. In response to questions and issues
raised by a CCG, the CRD team would synthesise
existing evidence together with relevant contextual
data to produce tailored evidence briefings to a
specified timescale agreed with the CCG. We
anticipated responding to six to eight substantive
issues per CCG during the intervention phase.
This was a responsive service, and CCGs could
contact the intervention team at any time to
request their services. Contact initiated by the
CRD intervention team was made on a monthly
basis and was expected to include discussion of
questions and priority topics and offers of advice
and support around identifying, appraising and
interpreting evidence. A full account of the
service offered is available elsewhere [20].
B. Contact plus an unsolicited push of non-tailored
evidence
CCGs allocated to this arm received on demand
access to advice and support from CRD as those
allocated to receive on demand access to the
evidence briefing service. However, the CRD
intervention team did not produce evidence
briefings in response to questions and issues raised
but instead disseminated the evidence briefings
generated in the responsive push intervention.
C. ‘Standard service’ unsolicited push of non-tailored
evidence
The third intervention constituted a ‘standard
service’ control arm; thus, an unsolicited push of
Fig. 1 Flow diagram of CCG recruitment
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non-tailored evidence. In this, CRD used email- and
web-based communication processes to disseminate
evidence briefings generated in intervention A and
any other non-tailored briefings produced by CRD
over the intervention period.
The intervention phase ran from the end of April
2014 to the beginning May 2015. As this study was
evaluating uptake of a demand-led service, the extent
to which the CCGs engaged with the interventions
was determined by the CCGs themselves.
Baseline and follow-up assessment
We collected data for our two primary outcome mea-
sures (perceived organisational capacity to use research
evidence and reported research use) at baseline (phase
1) and again 12 months after the intervention period
was completed (phase 3).
The survey instrument has been published and
described previously [21]. The instrument was designed to
collect four sets of information that assessed: the organisa-
tions’ ability to acquire, assess, adapt and apply research
evidence to support decision-making; the intentions of in-
dividual CCG staff to use research evidence in their
decision-making; perceptions of the quality and quantity
of interactions with researchers; and captured information
on individual respondent characteristics.
Survey administration
Each participating CCG supplied a list of names and email
addresses for potential respondents. These were checked
by a member of the evaluation team, and where inaccurate
or missing details were identified, these were sourced and
corrected. Survey instruments were sent by personalised
email to identified participants via an embedded URL.
The questionnaire was hosted by SurveyMonkey website
(http://www.surveymonkey.com). Reminder emails were
sent out to non-respondents at 2, 3 and 4 weeks. A paper
version was also posted out, and phone call reminders
were made by the research team. In addition, the named
contact in each CCG sent an email to all their colleagues
encouraging completion.
As CCGs were new and evolving entities at the time of
the study, we needed to be able to determine if any
changes viewed from baseline were linked to the inter-
vention(s) and were not just a consequence of the devel-
opment of the CCG(s) over the course of the study. To
guard against this maturation effect/bias and to test the
generalisability of findings, we administered Section A of
the instrument to all English CCGs to assess their
organisational ability to acquire, assess, adapt and apply
research evidence to support decision-making. The most
senior manager (chief operating officer or chief clinical
officer) of each CCG was contacted and asked to
complete the instrument on behalf of their organisation.
For the national survey, we used publically available infor-
mation (NHS England and CCG websites) supplemented
by phone calls to CCG headquarters to construct our
sampling frame consisting of every CCG in England.
Analysis
The primary analysis measured the effect of study inter-
ventions on two main outcomes at two time points:
baseline and 12 months. The key dependent variable was
CCG perceived organisational capacity to use research
evidence in their decision-making as measured by Sec-
tion A of the survey instrument. Following Norman [22],
we calculated the means, standard deviations and confi-
dence intervals for each of the seven subscales in the
instrument before and after the intervention period;
CCG capacity to acquire research, to look for research
in the right places, to tell if research is valid and of high
quality, to tell if research is relevant and applicable, to
summarise results in a user-friendly way, to lead by
example and value research use to support decision-
making processes for research use. We also calculated
an overall mean—of CCG capacity—and standard devi-
ation (mean of the sub scale means). Interpreting the
means is similar to the original scale: a mean score
nearer to 1 equates to very little capacity and a mean
score nearer to 5 indicates good capacity in the respect-
ive sub domain or for research evidence use generally.
We also measured the effect of interventions upon our
second main outcome of perceived research use and
CCG member’s intentions to use research. Based on the
theory of planned behaviour [23], we calculated means
for the four subscales in our survey instrument:
intention to use research, attitudes towards research,
group norms and perceived behavioural control. The
Likert scale used ranged from a score of 1, indicating the
lowest amount of the concept being measured (e.g. no
intention to use research) through to a score of 7 indi-
cating the highest amount of the concept being mea-
sured (e.g. the most positive attitudes towards research
use in a CCG).
We undertook a factorial ANOVA (SPSS version 22.0
general linear model procedure), comparing the main effect
of a single independent variable (CCG status) on a
dependent variable (capacity to acquire, assess, adapt and
apply research evidence to support decision-making) ignor-
ing all other independent variables (i.e. the effect ignoring
the potential for confounding from other independent
factors). A factorial ANOVA was also conducted to com-
pare the main effects of time and evidence briefing service
received and the interaction effect of time and evidence
briefing on intention to use research evidence (the
‘intention’ component of the survey instrument).
To examine the effects of (i) perceived contact and (ii)
the amount of perceived contact with the evidence
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briefing service, (iii) institutional support for research,
(iv) a sense of being equal partners during contact, (v)
common in-group identity, (vi) achievement of goals,
and (vii) perceptions of researchers generally, we under-
took a mixed 3 (intervention, A vs. B vs. C) × 2 (time,
baseline vs. outcome) ANOVA using SPSS version 22.0,
with the intervention as a between-subject independent
variable, and repeated measures on the second factor,
time.
Missing data
Only analysing the data for which we had complete re-
sponses could lead to potentially biased results [24], and
as anticipated at the protocol stage, the use of multiple
imputation techniques were required [25]. We assumed
that data were missing at random (visual comparison of
original vs. imputed data and significance testing of re-
sponse and nonresponse data impact on outcome vari-
ables). We used guidance on interpreting effect sizes in
before and after studies to examine the clinical/policy
significance of any changes [26].
Blinding
The CRD evidence briefing team were blinded from
both baseline and follow-up assessments until after all
the data collection was complete. The CRD team were
made aware of baseline and follow-up response rates.
Participating CCGs were also blinded from baseline and
follow-up assessments and analysis.
Qualitative evaluation
Part of our original plan was to collect and analyse
documentary evidence of the actual use of evidence in
decision-making using executive and governing body
meeting agendas, minutes and associated documents.
This was to be supplemented with interviews to explore
perceived use of evidence and any unanticipated conse-
quences. Early in the intervention phase, it became ap-
parent that with a few exceptions, there was a lack of
recorded evidence of research use (a finding in itself ).
Executive and governing body meetings were mainly
used to ratify recommendations and so would not tell us
anything about sources or processes. With research use
and decisions occurring elsewhere and often involving
informal processes, we undertook four case studies to
explore the use of research evidence in decision-making
in the intervention sites. A full account of case study
methods and analysis are available elsewhere [20].
Results
Over the course of the study, we addressed 24 questions
raised by the participating CCGs, 17 of which were
addressed during the intervention phase (see Table 1).
The majority of requests were focussed on options for
the delivery and organisation of a range of services and
way of working rather than on the effects of individual
interventions.
Requests for evidence briefings from the CCGs served
different purposes. Four broad categories of research use
have been proposed: conceptual (not directly linked to
discrete decisions but to provide knowledge about pos-
sible options for future actions); symbolic or tactical (to
justify existing decisions and actions); instrumental
(where evidence directly informs a discrete decision-
making process); and imposed (where there are organ-
isational, legislative or funding requirements that re-
search be used) [27, 28]. Derived through a consensus-
based approach, Table 1 shows that most requests re-
ceived were categorised as conceptual.
Response rates
Contact details for 181 baseline (A = 45; B = 61; C = 75)
and 168 follow-up (A = 43; B = 60; C = 65) participants
were supplied by CCGs; none were undeliverable.
In total, 123 questionnaires were returned at baseline
(A = 37/45; B = 54/61; C = 32/75) giving an overall re-
sponse rate of 68%. Of these, 101 were completed, 13
were deemed to be incomplete (one section or less com-
pleted) and 9 were from individuals declining to partici-
pate or indicating they had departed the CCG. At 1 year
follow-up, 76 questionnaires were returned (A = 23/43;
B = 28/60; C = 25/65) giving an overall response rate of
44%. Of these, 71 were completed, two were deemed to
be incomplete (one section or less completed) and three
were from individuals declining to participate or indicat-
ing they had departed the CCG.
Characteristics of respondents
Survey respondents reported holding a range of roles
within the CCGs. Most respondents were highly quali-
fied but only a minority reported having had prior ex-
perience in commissioning or undertaking research (see
Table 2). Sites with a lower response rate had a higher
proportion of clinically qualified respondents (X2 (2, N =
53) = 6.15, p = .05) but other than this difference, there
were no significant differences in the characteristics of
the respondents receiving the three interventions.
Overall capacity to acquire, assess, adapt and apply
research evidence to support decision-making
The total capacity to acquire, assess, adapt and apply
research evidence to support decision-making appeared
to improve slightly over time, irrespective of the pres-
ence of any intervention (Table 3). The main effect of
time in the factorial ANOVA yielded an F ratio of F(1,
127) = 4.49 p < .05 ηp
2 .034, indicating a significant differ-
ence over time in all three groups of CCGs total capacity
to acquire, assess, adapt and apply research evidence to
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Table 1 Questions addressed by the evidence briefing service
Source Topic Question Date asked Output
produced
Way research
used
A1 Urgent care services Evidence for implementing an ‘urgent
care hub’, consolidating out-of-hours
provision on a single site adjacent to
an accident and emergency department,
with front door triage assessing patients
for both facilities
Nov 2013 Evidence briefing Symbolic
A1 Supporting self-management:
helping people manage
long-term conditions
Rapid summary of the evidence relating
to self-care
Jan 2014 Evidence note Symbolic
All Urgent care services Evidence to inform urgent and
emergency care systems
March 2014 Evidence briefing Conceptual
A1 Loneliness and social isolation Interventions to reduce loneliness and
social isolation, particularly in elderly
people.
Apr 2014 Evidence briefing Conceptual
A1 Supporting self-management:
helping people manage
long-term conditions
Self-care support for people with COPD Apr 2014 Evidence briefing Conceptual
All Low value interventions Identify relevant recommendations
from the NICE Do Not Do database
May 2014 Evidence note Conceptual
A2, all Low value interventions Independent appraisal of evidence
underpinning 14 proposed value based
commissioning policies for MSK
procedures
July 2014 Evidence briefing Instrumental
A1 Community pharmacy minor
ailments service
Identify evidence to inform a review of
the community pharmacy minor
ailments service
July 2014 Evidence note Conceptual
A1 Integrated community teams Evidence for effects of integrated
community teams including any
examples of best practice
Aug 2014 Evidence note Conceptual
A2 Psychiatric Liaison Models of psychiatric liaison
implemented in general hospital settings
July 2014 Evidence note Instrumental
A1 ‘One stop shop’ screening
model for diabetes
Does implementing a comprehensive
one stop shop annual review and
screening model for diabetes have an
adverse impact on either the quality
or uptake
Sept 2014 Evidence note Symbolic
A2 Frailty What evidence/ validated tools are there
for frailty risk profiling in an A&E context
Oct 2014 Short email Note sufficient
to address question. Later
followed up with related
Effectiveness Matters on
recognising and managing
frailty in primary care
Conceptual
A2 Unplanned admissions from
care homes
What is the evidence for effects of
interventions to reduce inappropriate
admissions and deaths in hospital of
patients from care homes
Oct 2014 Evidence briefing Conceptual
A2 Social prescribing What is the effectiveness and cost
effectiveness evidence of social
prescribing programmes in primary care
Oct 2015 Evidence note and then later
updated into evidence briefing
Conceptual
A1 Supporting self-management:
helping people manage long-
term conditions
What is the evidence for the effects of
phone apps to help people to manage
their own care
Nov 2015 Evidence note Instrumental
A1 Supporting self-management:
helping people manage long-
term conditions
What is the evidence for the effects of
interventions to promote shared
decision-making
Nov 2015 Evidence note Conceptual
A1 Supporting self-management:
helping people manage long-
term conditions
What is the evidence for interventions
to support promoting patient-centred
care planning consultations
Nov 2015 Evidence briefing Conceptual
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support decision-making . The main effect of the
evidence briefing service received yielded an F ratio of
F(2, 127) = 0.77 p = >.5, ηp
2 .012. The interaction of time
and the intervention was also not significant yielding an
F ratio of F(2, 127) = 0.213 p > .05, ηp
2 .003. Exposure to
the intervention had no significant effect on perceived
CCG capacity.
Did the evidence briefing service improve CCGs’
intentions to use research evidence to support decision-
making?
As with the effect of the evidence briefing service on
capacity to use research for decision-making, we also
wanted to examine the effect on CCG’s collective
intention to use research evidence for decision-making.
Attitude towards the use of research in decision-making
was the strongest of these dimensions, and perceived be-
havioural control the weakest (Table 4). All intervention
groups had apparent small and non-statistically signifi-
cant declines in almost all of the theory of planned
behaviour dimensions from baseline to follow-up. This
difference is—in real terms—marginal: the positions
were broadly similar before and after encountering the
intervention.
Did the evidence briefing service improve CCGs’
perceptions of intergroup contact?
Perceptions of contact appeared generally more positive
from the start among the respondents receiving the evi-
dence briefing service than in the other intervention
groups (Table 5). There were increases in most other
dimensions of contact from baseline to follow-up across
the groups. None of these reached statistical significance,
and the magnitude of these gains appeared a little lower
in intervention A than in interventions B and C.
Table 1 Questions addressed by the evidence briefing service (Continued)
A1 Supporting self-management:
helping people manage long-
term conditions
Evidence for lay-led self-care education
programmes generally as part of creating
an environment and culture that supports
self-care
Nov 2015 Evidence briefing Conceptual
A1 Supporting self-management:
helping people manage long-
term conditions
An evidence based steer in how to give
patients the confidence and skills to
effectively self-manage their long-term
conditions.
Nov 2015 Evidence briefing Conceptual
A2 Accountable care organisations What is the evidence for accountable care
organisations
Apr 2015 Evidence note Conceptual
A2 Enhancing access in primary care What is the evidence for extended hours,
telephone consultation/triage, and role
substitution in enhancing access in primary
care
June 2015 Evidence briefing Conceptual
A2 Telehealth for COPD What lessons can be learned from previous
evaluations of the implementation of
telehealth for COPD
July 2015 Evidence note Instrumental
A1 Participatory democracy What is the evidence for different methods
of patient/public engagement in decision-
making
Aug 2015 Evidence note Conceptual
All Low-value interventions: existing
hernia and hysterectomy policies
Independent review of evidence for
existing hernia and hysterectomy policies
Aug 2015 Instrumental
Table 2 Characteristics of survey respondents
Intervention
received
A B C
n n n
Formal responsibility for
doing or managing research
in CCG?
Yes, doing and managing 5 2 2
Yes, managing 3 3 7
Yes, doing 1 2 0
Neither 28 35 17
Highest educational
achievement?
School level 2 0 0
Undergraduate 17 27 12
Master’s degree 14 13 8
Higher degree 3 2 6
Clinical qualifications? No 16 8 6
Yes 21 34 20
Worked as a researcher
in an academic context
No 34 42 24
Yes 5 11 13
Commissioned research No 29 47 32
Yes 10 6 5
Been a co-applicant or
advisor on a research
project
No 30 44 30
Yes 9 9 7
Been employed as a
researcher
No 35 49 32
Yes 4 4 5
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Did the evidence briefing service improve CCGs’
perceptions of researchers?
Using a ‘feeling thermometer’ measure where partici-
pants reported perceptions of researchers on a scale of 0
(very negative) to 100 (very positive). Perceptions of
researchers were positive among the respondents receiv-
ing intervention A, at baseline, almost at the level of the
post-intervention responses across the board.
There was a significant interaction between interven-
tion and time, F(2, 57) = 3.29, p = .045. Post hoc analyses
demonstrate that perceptions of researchers in general
were significantly more positive at the follow-up (M =
77.20) than at the baseline (M = 46.35) in intervention B,
(1, 19) = 9.76, p = .006. Similarly, perceptions of re-
searchers were also significantly more positive at the
outcome (M = 78.21) than at the baseline (M = 41.25) in
‘control’ intervention C, (1, 23) = 23.72, p = .0005. In
contrast, there was no change in attitude towards re-
searchers between the baseline (M = 67.31) and the out-
come (M = 72.69) in intervention A, F(1, 15) = 0.36, p
= .56. In sum, the evidence briefing service did not
change perceptions of researchers (in general).
Discussion
In this study, access to an evidence briefing service was
not associated with increases in CCG capacity to
acquire, assess, adapt and apply research evidence to
support decision-making.
Regardless of intervention received, at baseline, partici-
pating CCGs indicated that they lacked a consistent
approach to their research-seeking behaviours and their
capacity to acquire research remained so at follow-up.
CCGs were noncommittal (neither agreeing nor
disagreeing) on whether they had the capacity to assess
the quality, reliability and applicability of research for
use in decision-making. This perception remained un-
changed at follow-up. There was also no change on per-
ceptions of CCGs capacity to adapt and summarise
research results for use in decision-making; neither
agreeing nor disagreeing that the CCG had the capacity
to do so. Finally, individual’s perceptions that their CCG
did not have systems and processes in place to apply re-
search routinely also remained unchanged.
Exposure to the evidence briefing service did not
appear to have any effect on individuals’ intentions to
use research evidence in decision-making or their per-
ceptions of a shift in collective CCG norms towards the
use of research for decision-making. Regardless of inter-
vention received, these measures were positively orien-
tated at baseline and sustained at follow-up.
The respective baseline and follow-up response rates
of 68 and 44% are not unreasonable given the number of
Table 3 Intervention effects on CCG capacity to acquire, assess, adapt and apply research evidence to support decision-making
Domain Intervention received
A (n = 39) B (n = 53) C (n = 38)
Baseline Follow-up Baseline Follow-up Baseline Follow-up
Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI
Total 3.24 3.07–3.41 3.32 3.12–3.51 3.14 2.99–3.28 3.31 3.14–3.48 3.26 3.08–3.43 3.42 3.22–3.62
Acquire (staff) 2.95 2.70–3.18 2.91 2.58–3.22 2.84 2.64–3.05 3.02 2.75–3.29 3.29 2.94–3.43 3.03 2.71–3.35
Acquire (sources) 3.21 2.97–3.44 3.36 3.13–3.56 3.13 2.93–3.33 3.35 3.15–3.55 3.15 2.91–3.39 3.34 3.11–3.58
Assess evidence (staff) 3.04 2.8–3.29 3.34 3.09–3.58 3.28 3.07–3.49 3.42 3.22–3.62 3.36 3.12–3.61 3.27 3.03–3.51
Assess evidence (external expertise) 3.41 3.16–3.64 3.57 3.46–3.79 3.28 2.53–2.99 3.41 3.22–3.60 3.15 2.90–3.39 3.51 3.29–3.74
Adapt 3.09 2.82–3.36 3.29 3.04–3.54 2.76 2.53–2.99 3.12 2.91–3.34 3.10 2.83–3.37 3.24 2.98–3.49
Apply (leadership) 3.45 3.25–3.66 3.31 2.93–3.70 3.22 3.05–3.70 3.16 2.83–3.49 3.37 3.16–3.58 3.62 3.23–4.01
Apply (decision-making) 3.53 3.33–3.72 3.46 3.16–3.77 3.44 3.28–3.62 3.43 3.17–3.69 3.43 3.23–3.63 3.72 3.40–4.02
Table 4 Intervention impact on theory of planned behaviour domains
Theory of planned behaviour
domains
Intervention received
A (n = 39) B (n = 53) C (n = 38)
Baseline Follow-up Baseline Follow-up Baseline Follow-up
Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI
Intention 5.61 5.22–6.00 5.41 5.07–5.76 5.31 5.00–5.61 5.42 5.08–5.76 5.72 5.33–6.11 5.59 5.17–6.02
Attitudes 6.23 5.97–6.49 5.85 5.50–6.20 6.23 5.88–6.30 5.91 5.62–6.20 6.28 6.03–6.54 6.22 5.94–6.49
Group norms 5.18 4.85–5.52 4.77 4.24–5.29 5.03 4.77–5.30 5.02 4.60–5.44 5.39 5.02–5.76 5.43 5.08–5.78
Perceived behavioural control 5.01 4.69–5.33 4.85 4.30–5.40 4.95 4.64–5.25 4.36 3.87–4.85 4.85 4.37–5.33 5.07 4.67–5.47
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competing requests for information CCGs routinely are
faced with. Our response rates compare favourably with
other surveys conducted over the same time period [29,
30] and with a contemporaneous study of the effects of
an evidence service on policy makers’ use of research
evidence that failed to recruit [31, 32]. However, we ac-
knowledge that we experienced considerable attrition in
both baseline and follow-up surveys. In the study case
sites, the percentage of individuals completing both sur-
veys ranged from ~60% for those receiving intervention
A to ~30% in the CCGs who were allocated to receive
intervention C, the non-responsive version of the ser-
vice. As the turnover of CCG staff was relatively stable
over the course of the study, this may represent a degree
of selection bias.
We were reliant on the quality of the sampling frames
provided by each CCG. We found that contact informa-
tion provided by CCGs, and especially that sourced for
the national benchmarking component of the study, was
sometimes inaccurate and or incomplete. As such, each
CCG had to be contacted to obtain, check and recheck
the contact details of the staff provided.
We utilised an 87-item questionnaire to collect data
relevant to the primary outcome, and although all re-
sponses were on short scales (no open responses), pilot-
ing estimated that it would take participants up to
45 min to complete. We employed a range of factors to
increase the odds of response including, prenotification,
follow-up contact, online and postal formats, reminder
copies, CCG and university sponsorship [33]. We are
aware that both shorter questionnaires and financial in-
centives are also associated with increased response rates
[33]. In this instance, it may be that the perceived return
for time invested of access to a funded evidence briefing
service either immediately or after the intervention
phase was complete (the offer made to participants in
the ‘control’ intervention C) and was deemed inadequate
compensation by some participants. The CCGs allocated
to intervention C had expressed initial enthusiasm for
participation. However, the lack of any immediate return
from or a sufficient relationship with the evidence
briefing service over the course of the study may go
some way to explaining why those allocated to the ‘con-
trol’ had the lowest response rate. Survey length may
also have contributed to the lack of completeness in the
data collected.
Given these limitations, we have been cautious in our
interpretation of any apparent effect of the evidence
briefing service on the primary outcome measures. In-
deed, we have been careful to avoid the pitfalls of p
values in assessing whether this study provides evidence
‘for’ or ‘against’ rejection of the null hypothesis [34].
Whilst the statistical tests applied generated some appar-
ent statistical differences beyond that which we would
have expected to see by chance, we think appropriate
caution is necessary in interpreting the real world sig-
nificance of what was observed. It would be reasonable
to consider a shift of at least one point on any Likert
scale as indicative of some effect and anything lower ob-
served (i.e. no shift on the scale) as unlikely to be behav-
iourally significant.
Analysis undertaken to trace evidence briefings re-
vealed with few exceptions a lack of recorded evidence
of use. Most discussions between contacts in CCGs and
the evidence briefing team were informal and rarely in-
volved minuted meetings or formal gatherings of CCG
staff. Indeed, we were often responding to requests from
one, two or three named individuals who would be lead-
ing a piece of work or clinical area on behalf of the CCG
as a whole. As such, analysis of records supporting the
more formal executive and governing body meetings
provided little information about sources used or the
decision-making process itself. The ‘unseen and informal
spaces’ [35] of decision-making processes, the small
numbers of staff involved and the reality that no audit
trail existed for sources used during these processes
meant that there was little or no ‘traceability’ [36] of use
of evidence briefings at an organisational level. Our ex-
perience aligns well with others who have faced similar
challenges identifying whether systematic reviews are
used and the extent to which they add value to decision-
making processes in public health [36].
Table 5 Intervention impact on perceptions of intergroup contact between CCGs and researchers
Perceived intergroup contact Intervention received
A (n = 39) B (n = 53) C (n = 38)
Baseline Follow-up Baseline Follow-up Baseline Follow-up
Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI
Amount of contact 1.76 1.2–2.36 2.11 1.82–2.42 1.17 0.65–1.69 1.72 1.45–2.01 1.16 0.70–1.62 1.92 1.67–2.17
Quality of contact 4.60 3.09–6.11 5.66 5.21–6.11 3.19 1.68–4.67 5.96 5.51–6.41 2.89 1.62–4.13 5.61 5.23–5.99
Institutional (CCG) support for contact 4.60 3.45–5.67 5.12 4.48–5.75 2.68 1.63–3.74 4.61 4.01–5.20 2.56 1.63–3.50 4.79 4.26–5.32
Equal status during contact 4.74 3.56–5.96 4.97 4.57–5.30 3.03 1.92–4.13 4.11 3.73–4.48 2.77 1.78–3.75 4.46 4.12–4.79
Common in-group identity 3.88 2.83–4.92 4.44 4.06–4.81 2.68 1.70–3.66 4.34 3.99–4.69 2.60 1.73–3.47 4.54 4.22–4.85
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In this study, we sought to add insight as to how much
added value the service would offer over alternative or
more basic approaches. The evidence briefing service as
constituted represented a resource intensive intervention.
There was sustained engagement by individuals in the
CCGs receiving the evidence briefing service, and because
we employed a degree of flexibility in the service delivered
(employing a combination of full evidence briefings and
shorter more exploratory evidence notes in response to
questions raised), we were able to deliver a number of out-
puts beyond our original. However, impact on explicit in-
strumental decision-making processes was limited. Whilst
we recognise that conceptual use of research to raise aware-
ness and increase knowledge is an entirely appropriate goal
in itself, we would question whether this represents a suffi-
cient level of impact to justify sustaining a resource inten-
sive intervention of this type.
The impact of evidence briefings on explicit instru-
mental decision-making processes was limited to estab-
lishing region wide policies relating to interventions of
no or low clinical benefit; a process that needed to be
both transparent and defendable for participating CCGs.
This study may suggest that it is at this meso level where
services packaging evidence derived from systematic re-
views may most efficiently be deployed to impact on
decision-making in a commissioning context. Disinvest-
ment decisions relating to interventions of no or low
clinical value remain high on the commissioning agenda.
And in our study, established processes to harness re-
search evidence for this type of policy formulation were
lacking.
If meso level activity may represent the best focus for
resource intensive services, we still need to consider
how to systematise research use among individual CCGs.
The SPIRIT Action Framework hypothesises that a cata-
lyst is required for the use of research, the response to
which is determined by the capacity of the organisation
to engage with available research [37]. Where there is
sufficient capacity, a series of research engagement ac-
tions might occur that facilitate research use. The
Framework predicts that the greater the organisational
capacity, the more research engagement actions (acces-
sing and appraising research, generating new research
and interacting with researchers) will occur which will in
turn result in a greater use of research evidence. Using
the Framework to reflect on this study, we had catalysts
and engagement opportunities (around the questions
raised and the briefings produced), but the service as
constituted did little to enhance the capacity of the or-
ganisation to engage with research. Both baseline and
follow-up data suggest that commissioners are well
intentioned ad hoc users of research evidence and that
they work in a setting where there is a lack of systems
and processes to do this routinely. This suggests a
knowledge and skills gap that this study has not ad-
dressed. The evidence briefing team offered training on
how to acquire, assess, adapt and apply evidence to
CCGs receiving the evidence briefing service or inter-
vention B. Training could have in part addressed these
knowledge and skills gaps, but the offers were not taken
up. Rather than making training a demand-led ‘offer’, it
may have been better to identify the capacity for re-
search use of each CCG at the outset, and then to pro-
vide training relevant to their current state. At the very
least, this study has highlighted the importance of build-
ing organisational capacity as a component of evidence
use, an area that appears to be under researched [38].
Public health specialists have traditionally supported
and facilitated the use of research evidence in a commis-
sioning context [39–41]. Throughout this study, we ob-
served that despite its relocation to local government,
public health specialist remained accessed by CCGs des-
pite being no longer central to decision-making pro-
cesses. Some senior staff in participating CCGs had
much prior experience of support from public health
teams under previous commissioning arrangements.
And as the interventions followed soon after the preced-
ing arrangements had ceased, it is perhaps no surprise
that the CCG commissioning staff made use of the ser-
vice offered by CRD. Nevertheless, all the CCGs contin-
ued to place value on the knowledge and expertise of
trusted ‘critical friends’ [42] in the shape of public health
consultants. They provided a bridge between the old and
new commissioning arrangements and brought valuable
insights and networks from beyond the boundaries of
the CCG. Although we often observed commissioners
looking out and undertaking fact finding trips to see
what other CCGs around the country were doing, the
same individuals were often unaware that colleagues in
adjacent areas were undertaking similar work or grap-
pling with similar questions. Public health specialists
were the individuals viewed most likely to fill this local
knowledge gap and to mitigate against a general dissatis-
faction with the knowledge-sharing capabilities of the
formal Commissioning Support arrangements. Whether
fair or otherwise, there was a general perception among
CCG informants that the Commissioning Support lacked
the necessary infrastructure and or expertise to
efficiently acquire, assess and adapt research for use in
decision-making. The one-to-one transactional arrange-
ments Commissioning Support had with CCGs were
themselves viewed as a barrier to wider knowledge
sharing across the region. This danger of ‘network
closure’ undermining local knowledge sharing and
historically trusted relationships has been anticipated
previously [43].
Wye and colleagues have argued that researchers need
to build relationships and engage with commissioners
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locally using commissioners’ preferred methods of conver-
sations and stories, to find out what is wanted and how
best to deliver it [41]. Whilst we do not discourage the
cultivation of these relationships, the reality of the
decision-making process is that any engagement is
resource intensive and so researchers need to carefully
consider how best to target those relations that will deliver
the best return. Somebody needs to be around or ‘in the
room’ when ideas first germinate, to spot the potential cat-
alysts to research use and to question what is the evidence
for this? Why do we want to pursue this course of action?
Given this, Wye et al.’s suggestion that researchers culti-
vate relationships with local public health teams could
represent the intermediary channel through which the use
of research by individual CCGs can be influenced [41].
Public health staff are more likely to be ‘in the room’ and
have the necessary skills and local networks to facilitate
knowledge sharing within and across commissioning land-
scape. The current emphasis on innovation and the devel-
opment of new models of health and social care is
favouring coproduction approaches to the design,
commissioning and delivery of services. This shift may
strengthen the intermediary role of public health. But if
this intermediary role is to be sustained, public health spe-
cialists will need to be supported and resourced to return
to playing a more central role in commissioning.
Alongside capacity building and engagement, macro
level intervention is also needed to enhance research use
at the level of the individual CCG. The Health and
Social Care Act mandates research use as a core consid-
eration but, whereas the current policy climate explicitly
incentivises innovation and integration, there is no
equivalent incentive for finding and applying research to
support the many decisions required to turn this vision
into a reality. The CCG Assurance Framework focuses
on leadership, financial and performance management,
planning and delegated functions but contains no spe-
cific metrics on whether CCGs are fulfilling their statu-
tory duties in respect of use of evidence obtained from
research [44]. If we are serious about shifting CCGs
from being well intentioned but inconsistent users of re-
search evidence then a more explicit set of requirements
may be necessary. Ideally, the incentive structure that
exists for health service innovation and integration may
need to be replicated to support CCGs fulfilment of
their statutory duties in respect of the use of research
under the Act. Without this, the current ad hoc engage-
ment with research is likely to remain.
We are conscious that our findings relate to a specific
decision-making context and setting and have been gen-
erated at time when the commissioning arrangements
are rapidly evolving. Given this, further comparative
evaluation and clarification of the role and value of simi-
lar demand-led evidence briefing services in other
context and settings may be warranted. The SPIRIT
Action Framework may provide a guide upon which the
evaluation of any future services seeking to increase the
use of research in policy can be based [37].
Conclusions
Access to a demand-led evidence briefing service as con-
stituted in this study did not improve the uptake and
use of research evidence by NHS commissioners com-
pared with less intensive and less targeted alternatives.
Our study suggests commissioners are well intentioned
but lack access to the necessary skills and infrastructure
to make use of research evidence routine.
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